Otis W Brawley is a director of Lyell Immunopharma Inc.
Person profile
Roles
Address
Buford, Georgia
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
AGILENT TECHNOLOGIES, INC.
19 Mar 24
4
Lyell Immunopharma, Inc.
8 Sep 23
4
PDS Biotechnology Corp
17 Jul 23
4
Lyell Immunopharma, Inc.
20 Jun 23
4
INCYTE CORP
16 Jun 23
4
AGILENT TECHNOLOGIES, INC.
20 Mar 23
4
PDS Biotechnology Corp
29 Jun 22
4
INCYTE CORP
17 Jun 22
4
Lyell Immunopharma, Inc.
10 Jun 22
4
AGILENT TECHNOLOGIES, INC.
21 Mar 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | A Agilent | Common Stock | Grant | Acquire A | No | No | 147.48 | 750 | 110.61 k | 8,055.457 |
15 Mar 24 | A Agilent | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 7,305.457 |
8 Sep 23 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 3.19 | 55,000 | 175.45 k | 55,000 |
14 Jul 23 | PDSB PDS Biotechnology | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 5.13 | 9,000 | 46.17 k | 9,000 |
14 Jun 23 | INCY Incyte | Common Stock | Grant | Acquire A | No | No | 0 | 2,505 | 0.00 | 5,904 |
14 Jun 23 | INCY Incyte | NQSO Common Stock | Grant | Acquire A | No | No | 61.44 | 11,294 | 693.90 k | 11,294 |
16 Mar 23 | A Agilent | Common Stock | Grant | Acquire A | No | No | 136.82 | 741 | 101.38 k | 5,585.276 |
16 Mar 23 | A Agilent | Common Stock | Grant | Acquire A | No | No | 136.82 | 1,658 | 226.85 k | 4,844.276 |